Wolverine Trading
AMAG

Wolverine Trading’s AMAG Pharmaceuticals AMAG Stock Holding History

Wolverine Trading’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-14,800
Closed -$137K – 5742
2020
Q3 		$137K Buy
14,800
+1,800
+14% +$17.1K ﹤0.01% 4016
2020
Q2 		$98K Buy
+13,000
New +$99.5K ﹤0.01% 4142
2019
Q4 		– Sell
-34,600
Closed -$419K – 5484
2019
Q3 		$419K Buy
34,600
+3,400
+11% +$35.8K ﹤0.01% 2813
2019
Q2 		$312K Buy
31,200
+15,300
+96% +$165K ﹤0.01% 3225
2019
Q1 		$205K Buy
+15,900
New +$237K ﹤0.01% 3797
2018
Q4 		– Sell
-23,200
Closed -$464K – 5725
2018
Q3 		$464K Buy
+23,200
New +$528K ﹤0.01% 3198
2017
Q3 		– Sell
-38,000
Closed -$694K – 5321
2017
Q2 		$694K Sell
38,000
-2,200
-5% -$43.6K ﹤0.01% 2108
2017
Q1 		$923K Buy
+40,200
New +$962K 0.01% 1787
2016
Q4 		– Sell
-39,800
Closed -$957K – 5447
2016
Q3 		$957K Buy
+39,800
New +$995K ﹤0.01% 1902

Wolverine Trading's AMAG Position: Q2 2017 in Review

Wolverine Trading sold out of AMAG Pharmaceuticals (AMAG) in Q2 2017, closing a stake of 19,069 shares — an estimated $378K sold.

Wolverine Trading first reported a position in AMAG in Q1 2017 and held it in 1 quarter. The position peaked at $438K in Q1 2017. 174 funds tracked by Wall St. Rank hold AMAG as of Q2 2017.

  • Wolverine Trading reported no remaining AMAG Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Wolverine Trading sold 19,069 AMAG Pharmaceuticals shares in Q2 2017, an estimated $378K.
  • Wolverine Trading first reported a position in AMAG Pharmaceuticals in Q1 2017 and held it in 1 quarter.
  • Wolverine Trading's AMAG Pharmaceuticals position peaked at $438K in Q1 2017.
  • 174 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2017.

Based on Wolverine Trading's 13F filing for Q2 2017, filed 14 Aug 2017.